Analyst Ratings for Anthera Pharma (ANTH)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/12/2018 | Piper Sandler | N/A | Downgrade | Underweight (Overweight) |
0.10 (4.00) |
0.33 (0.00) |
-100% | Details |
| 2/21/2018 | Roth/MKM | N/A | New Coverage | Buy (N/A) |
10.00 (N/A) |
1.69 (0.00) |
-100% | Details |
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||
![]() |
||||||||


